Universidad Complutense de Madrid
Quick facts
| Founded | 1972 |
|---|
Marketed products
- 70% alcohol
- 70% alcohol - 0.5% clorhexidine
- Amoxicillin-Potassium Clavulanate Combination · Infectious Disease
Amoxicillin inhibits bacterial cell wall synthesis while potassium clavulanate protects amoxicillin from degradation by bacterial beta-lactamases, extending its spectrum of activity. - Antiinflammatories · Other
- Application of Enamel Matrix Derivatives · Dentistry / Periodontics
Enamel matrix derivatives promote periodontal tissue regeneration by mimicking the natural proteins present during tooth development and stimulating the migration and differentiation of periodontal ligament cells. - Emdogain (EMD) - test · Dentistry / Periodontics
Emdogain is a protein extract derived from developing tooth buds that promotes periodontal regeneration by stimulating growth factors and extracellular matrix formation. - Hand antisepsis by scrub · Infection Prevention / Surgical Prophylaxis
Hand antisepsis by scrub mechanically removes and chemically inactivates microorganisms from the skin surface through friction and antimicrobial agents. - NBF · Diabetes
NBF is a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
Phase 2 pipeline
- Lactobacillus fermentum LC40
- Lactobacillus reuteri CR20
- Lactobacillus salivarius CECT5713
- Lactobacillus salivarius HN6
Phase 1 pipeline
- Aplicación de melatonina
- Lactobacillus salivarius PS2
- Ligilactobacillus salivarius MP101
- Monolithic zirconia
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Universidad Complutense de Madrid portfolio CI brief
- Universidad Complutense de Madrid pipeline updates RSS
Frequently asked questions about Universidad Complutense de Madrid
What are Universidad Complutense de Madrid's marketed drugs?
Top marketed products include 70% alcohol, 70% alcohol - 0.5% clorhexidine, Amoxicillin-Potassium Clavulanate Combination, Antiinflammatories, Application of Enamel Matrix Derivatives, Emdogain (EMD) - test.
When was Universidad Complutense de Madrid founded?
Universidad Complutense de Madrid was founded in 1972.
Related
- 70% alcohol
- 70% alcohol - 0.5% clorhexidine
- Amoxicillin-Potassium Clavulanate Combination · Infectious Disease
- Antiinflammatories · Other
- Application of Enamel Matrix Derivatives · Dentistry / Periodontics
- Sector hub: All tracked pharma companies